NEWS & VIEWS
FDA Says Only One Pivotal Clinical Trial Now Required for New Drug Approval
Additional Confirmatory Evidence Will Still Be Expected
Big Changes Coming for INDs, BLAs, & NDAs (Module 3 and Module 2.3)
First Major Revisions to the Common Technical Document (CTD) CMC Section Guidance in 25 Years